Perceptions and Representations of Vaccination Against COVID-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

14 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-09-01

Study Completion Date

2022-09-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

SARS COV2, the virus that causes COVID-19, was first described in Wuhan, China. For this pathology, which causes severe respiratory infections, preventing the transmission of the virus has become fundamental, that is why vaccines have been developed. In France, this vaccination campaign took place in a context where the lack of confidence in vaccination is high:

According to a November 2020 IFOP poll, only 41% of French respondents were willing to be vaccinated against COVID-19.

To our knowledge, there are still few qualitative studies on vaccination on the current issue of vaccination against COVID-19.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Group Intervention on Vaccine Confidence

NCT05891626

Vaccination Refusal

UNKNOWN NA

COVID-19 and Vaccination Attitudes

NCT04352582

COVID-19

COMPLETED

Testing a Personalized Normative Feedback Intervention for Vaccine Hesitancy

NCT05787015

COVID-19 Vaccine Hesitancy

UNKNOWN NA

Understanding Public Attitudes Towards the COVID-19 Vaccination

NCT05023512

Covid19 Vaccination

WITHDRAWN NA

Facial Hair, PPE and COVID-19

NCT04579627

COVID Safety Issues

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

COVID-19 Acute Respiratory Distress Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Interview

Face to face semi-directed interviews about perceptions, representations and experiences of Covid-19 vaccination, including six opened-questions

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Over 18 years of age
* Patient with a scheduled appointment in consultation or at the vaccination centre
* Not opposed to participation in the protocol

Exclusion Criteria

* Patient under guardianship or curatorship
* Patient unable to give free and informed consent
* Patient under court protection
* Patient without the cognitive capacity to ensure an interview

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No